Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.455
+0.045 (1.32%)
Mar 14, 2025, 11:33 AM EDT - Market open

Relay Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-337.71-341.97-290.51-363.87-52.41
Upgrade
Depreciation & Amortization
5.465.274.133.933.55
Upgrade
Asset Writedown & Restructuring Costs
---123-
Upgrade
Loss (Gain) From Sale of Investments
-12.42-10.761.1813.91-0.42
Upgrade
Stock-Based Compensation
94.1486.0356.1448.4531.96
Upgrade
Other Operating Activities
-13.21-6.42-11.682.84-
Upgrade
Change in Accounts Receivable
-5.22-0.2877.79-82.65
Upgrade
Change in Accounts Payable
10.27-9.5911.290.93-0.41
Upgrade
Change in Unearned Revenue
7.68--0.25--
Upgrade
Change in Other Net Operating Assets
-3.33-28.090.4818.62-2.11
Upgrade
Operating Cash Flow
-249.11-300.32-229.49-74.41-102.49
Upgrade
Capital Expenditures
-2.02-4.13-9.06-3.47-1.93
Upgrade
Cash Acquisitions
----25.3-
Upgrade
Investment in Securities
-39.07261.76-179.68-450.7483.6
Upgrade
Investing Cash Flow
-41.08257.63-188.75-479.5181.67
Upgrade
Issuance of Common Stock
270.1534.75289.91388.09426.51
Upgrade
Financing Cash Flow
270.1534.75289.91388.09426.51
Upgrade
Net Cash Flow
-20.04-7.93-128.33-165.83405.69
Upgrade
Free Cash Flow
-251.13-304.44-238.55-77.88-104.42
Upgrade
Free Cash Flow Margin
-2509.49%-1191.74%-17273.86%-2571.05%-126.33%
Upgrade
Free Cash Flow Per Share
-1.76-2.48-2.13-0.82-2.45
Upgrade
Levered Free Cash Flow
-131.63-183.52-108.6-8.17-87.24
Upgrade
Unlevered Free Cash Flow
-131.63-183.52-108.6-8.17-87.24
Upgrade
Change in Net Working Capital
-11.8333.56-34.54-84.2485.95
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.